An increase of toxic bile acids such as glycochenodeoxycholic acid occurs during warm ischemia reperfusion causing cholestasis and damage in hepatocytes and intrahepatic biliary epithelial cells. We aim to test antiapoptosis effects of ursodeoxycholyl lysophosphatidylethanolamide under cholestatic induction by glycochenodeoxycholic acid treatment of mouse hepatocytes and hypoxia induction by cobalt chloride treatment of intrahepatic biliary epithelial cancer Mz-ChA-1cell line. Such treatments caused marked increases in apoptosis as evidenced by activation of caspase 3, caspase 8 and poly (ADP-ribose) polymerase-1. Co-treatment with ursodeoxycholyl lysophosphatidylethanolamide significantly inhibited these increases. Interestingly, ursodeoxycholyl lysophosphatidylethanolamide was able to increase expression of antiapoptotic cellular FLICE-inhibitory protein in both cell types. Ursodeoxycholyl lysophosphatidylethanolamide also prevented the decreases of myeloid cell leukemia sequence-1 protein in both experimental systems, and this protection was due to ursodeoxycholyl lysophosphatidylethanolamide’s ability to inhibit ubiquitination-mediated degradation of myeloid cell leukemia sequence-1, and to increase the phosphorylation of GSK-3β. In addition, ursodeoxycholyl lysophosphatidylethanolamide was able to prevent the decreased expression of another antiapoptotic cellular inhibitor of apoptosis 2 in cobalt chloride-treated Mz-ChA-1 cells. Hence, ursodeoxycholyl lysophosphatidylethanolamide mediated cytoprotection against apoptosis during toxic bile-acid and ischemic stresses by a mechanism involving accumulation of cellular FLICE-inhibitory protein, myeloid cell leukemia sequence-1 and cellular inhibitor of apoptosis 2 proteins. Ursodeoxycholyl lysophosphatidylethanolamide may thus be used as an agent to prevent hepatic ischemia reperfusion.
LemastersJJThurmanRG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol1997; 37: 327–38.
2.
KatyalSOliverJHBuckDGFederleMP. Detection of vascular complications after liver transplantation. Am J Roentgenol2000; 175: 1735–39.
3.
CutrinJCCantinoDBiasiFChiarpottoESalizzoniMAndornoEMassanoGLanfrancoGRizzettoMBoverisA. Reperfusion damage to the bile canaliculi in transplanted human liver. Hepatology1996; 24: 1053–57.
4.
YasuiHYoshimuraNKobayashiYOchiaiSMatsudaTTakamatsuTOkaT. Microstructural changes of bile canaliculi in canine liver: the effect of cold ischemia reperfusion in orthotopic liver transplantation. Transplant Proc1998; 30: 3754–57.
5.
GeukenEVisserDKuipersFBlokzijlHLeuveninkHGde JongKPPeetersPMJansenPLSlooffMJGouwASPorteRJ. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol2004; 41: 1017–25.
6.
GreimHTrulzschDCzyganPRudickJHuttererFSchaffnerFPopperH. Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction. Gastroenterology1972; 63: 846–50.
7.
FaubionWAGuicciardiMEMiyoshiHBronkSFRobertsPJSvingenPAKaufmannSHGoresGJ. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest1999; 103: 137–45.
8.
HoekstraHPorteRJTianYJochumWStiegerBMoritzWSlooffMJGrafRClavienPA. Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/− mice. Hepatology2006; 43: 1022–31.
9.
LigeretHBraultAVallerandDHaddadYHaddadPS. Antioxidant and mitochondrial protective effects of silibinin in cold preservation-warm reperfusion liver injury. J Ethnopharmacol2008; 115: 507–14.
10.
KinciusMLiangRNickkholghAHoffmannKFlechtenmacherCRyschichEGuttCNGebhardMMSchmidtJBüchlerMWSchemmerP. Taurine protects from liver injury after warm ischemia in rats: the role of kupffer cells. Eur Surg Res2007; 39: 275–83.
11.
FalascaLTisoneGPalmieriGAnselmoADi PaoloDBaiocchiLTorriEOrlandoGCascianiCUAngelicoM. Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation2001; 71: 1268–76.
12.
SchindlerGKinciusMLiangRBackhausJZornMFlechtenmacherCGebhardMMBüchlerMWSchemmerP. Fundamental efforts toward the development of a therapeutic cocktail with a manifold ameliorative effect on hepatic ischemia/reperfusion injury. Microcirculation2009; 16: 593–602.
13.
BenzCAngermullerSToxUKloters-PlachkyPRiedelHDSauerPStremmelWStiehlA. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol1998; 28: 99–106.
14.
ChamulitratWBurhenneJRehlenTPathilAStremmelW. Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent. Hepatology2009; 50: 143–54.
15.
ChamulitratWLiebischGXuWGan-SchreierHPathilASchmitzGStremmelW. Ursodeoxycholyl lysophosphatidylethanolamide inhibits lipoapoptosis by shifting fatty acid pools toward monosaturated and polyunsaturated fatty acids in mouse hepatocytes. Mol Pharmacol2013; 84: 696–709.
16.
KnuthAGabbertHDippoldWKleinOSachsseWBitter-SuermannDPrellwitzWMeyer zum BuschenfeldeKH. Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol1985; 1: 579–96.
17.
PalmeiraCMRoloAP. Mitochondrially-mediated toxicity of bile acids. Toxicology2004; 203: 1–15.
18.
IizakaTTsujiMOyamadaHMorioYOguchiK. Interaction between caspase-8 activation and endoplasmic reticulum stress in glycochenodeoxycholic acid-induced apoptotic HepG2 cells. Toxicology2007; 241: 146–56.
19.
ScaffidiCSchmitzIKrammerPHPeterME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem1999; 274: 1541–48.
Sánchez-PérezTOrtiz-FerrónGLópez-RivasA. Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents. Cell Death Differ2010; 17: 883–94.
22.
KimHJYangSJKimYSKimTU. Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase activation in human cervical cancer HeLa cells. J Biochem Mol Biol2003; 36: 468–74.
23.
JungJYKimWJ. Involvement of mitochondrial- and Fas-mediated dual mechanism in CoCl2-induced apoptosis of rat PC12 cells. Neurosci Lett2004; 371: 85–90.
24.
PetitAMwaleFZukorDJCatelasIAntoniouJHukOL. Effect of cobalt and chromium ions on bcl-2, bax, caspase-3, and caspase-8 expression in human U937 macrophages. Biomaterials2004; 25: 2013–8.
25.
Ishioka T, Katayama R, Kikuchi R, Nishimoto M, Takada S, Takada R, Matsuzawa S, Reed JC, Tsuruo T, Naito M Impairment of the ubiquitin-proteasome system by cellular FLIP. Genes Cells 2007;12:735-44.
26.
NishiharaHKizaka-KondohSInselPAEckmannL. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. Proc Natl Acad Sci U S A2003; 100: 8921–6.
27.
BeilkeLDAleksunesLMOlsonERBesselsenDGKlaassenCDDvorakKCherringtonNJ. Decreased apoptosis during CAR-mediated hepatoprotection against lithocholic acid-induced liver injury in mice. Toxicol Lett2009; 188: 38–44.
28.
LeeMLaphamABrimmellMWilkinsonHPackhamG. Inhibition of proteasomal degradation of Mcl-1 by cobalt chloride suppresses cobalt chloride-induced apoptosis in HCT116 colorectal cancer cells. Apoptosis2008; 13: 972–82.
29.
ZhongQGaoWDuFWangX. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell2005; 121: 1085–95.
30.
MaurerUCharvetCWagmanASDejardinEGreenDR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell2006; 21: 749–60.
31.
ZhaoYAltmanBJColoffJLHermanCEJacobsSRWiemanHLWoffordJADimascioLNIlkayevaOKelekarAReyaTRathmellJC. Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1. Mol Cell Biol2007; 27: 4328–39.
32.
FrameSCohenP. GSK3 takes centre stage more than 20 years after its discovery. Biochem J2001; 359: 1–16.
33.
TokiFTakahashiASuzukiMOotakeSHiratoJKuwanoH. Development of an experimental model of cholestasis induced by hypoxic/ischemic damage to the bile duct and liver tissues in infantile rats. J Gastroenterol2011; 46: 639–47.
34.
FouassierLBeaussierMSchifferEReyCBarbuVMergeyMWendumDCallardPScoazecJYLasnierEStiegerBLienhartAHoussetC. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. Am J Physiol Gastrointest Liver Physiol2007; 293: G25–35.
35.
NowakGNorénUGWernersonAMarschallHUMöllerLEriczonBG. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats. Transpl Int2005; 17: 804–9.
36.
KreuzSSiegmundDScheurichPWajantH. NF-kappaB inducers upregulatecFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol2001; 21: 3964–73.
37.
Halder UC, Bhowmick R, Roy Mukherjee T, Nayak MK, Chawla-Sarkar M Phosphorylation drives an apoptotic protein to activate antiapoptotic genes: paradigm of influenza A matrix 1 protein function. J Biol Chem 2013;288:14554-68.
38.
OhHYNamkoongSLeeSJPorEKimCKBilliarTRHanJAHaKSChungHTKwonYGLeeHKimYM. Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP. Cell Death Differ2006; 13: 512–23.
39.
RenFDuanZChengQShenXGaoFBaiLLiuJBusuttilRWKupiec-WeglinskiJWZhaiY. Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism. Hepatology2011; 54: 687–96.
40.
ShinoharaMYbanezMDWinSThanTAJainSGaardeWAHanDKaplowitzN. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J Biol Chem2010; 285: 8244–55.
41.
BertrandMJMilutinovicSDicksonKMHoWCBoudreaultADurkinJGillardJWJaquithJBMorrisSJBarkerPA. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell2008; 30: 689–700.
42.
VarfolomeevEGoncharovTFedorovaAVDynekJNZobelKDeshayesKFairbrotherWJVucicD. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem2008; 283: 24295–9.
43.
ZúñigaJCancinoMMedinaFVarelaPVargasRTapiaGVidelaLAFernándezV. N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS One2011; 6: e28502–e28502.
44.
DuCFangMLiYLiLWangX. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell2000; 102: 33–42.
45.
VerhagenAMEkertPGPakuschMSilkeJConnollyLMReidGEMoritzRLSimpsonRJVauxDL. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell2000; 102: 43–53.
